metricas
covid
Buscar en
Revista Argentina de Microbiología
Toda la web
Inicio Revista Argentina de Microbiología Role of Proteus mirabilis flagella in biofilm formation
Información de la revista
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
2316
Original article
Acceso a texto completo
Role of Proteus mirabilis flagella in biofilm formation
Papel de los flagelos de Proteus mirabilis en la formación de biofilms
Visitas
2316
Paola Scavonea, Victoria Iribarnegaraya,c, María José Gonzáleza, Nicolás Navarroa, Nicole Caneles-Huertab, Jorge Jara-Wildeb, Steffen Härtelb, Pablo Zuninoa,
Autor para correspondencia
a Department of Microbiology, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay
b Laboratory for Scientific Image Processing (SCIAN-Lab), Biomedical Neuroscience Institute (BNI), Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile
c Department of Pathobiology, Facultad de Veterinaria, Universidad de la República, Montevideo, Uruguay
Highlights

  • P. mirabilis flagella have a medium-dependent role in cellular hydrophobicity.

  • All motility and catheter migration models showed a significant role of flagella.

  • A flagellate P. mirabilis mutant was outcompeted by the wild-type in biofilms.

  • Biofilm formation of the mutant was impaired as seen in different in vitro assays.

  • Flagellar function could be targeted to prevent biofilm formation.

Este artículo ha recibido
Recibido 05 Septiembre 2022. Aceptado 25 Enero 2023
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (6)
Mostrar másMostrar menos
Material adicional (1)
Abstract

Proteus mirabilis(P. mirabilis) is a common etiological agent of urinary tract infections, particularly those associated with catheterization. P. mirabilis efficiently forms biofilms on different surfaces and shows a multicellular behavior called ‘swarming’, mediated by flagella. To date, the role of flagella in P. mirabilis biofilm formation has been under debate. In this study, we assessed the role of P. mirabilis flagella in biofilm formation using an isogenic allelic replacement mutant unable to express flagellin. Different approaches were used, such as the evaluation of cell surface hydrophobicity, bacterial motility and migration across catheter sections, measurements of biofilm biomass and biofilm dynamics by immunofluorescence and confocal microscopy in static and flow models. Our findings indicate that P. mirabilis flagella play a role in biofilm formation, although their lack does not completely avoid biofilm generation. Our data suggest that impairment of flagellar function can contribute to biofilm prevention in the context of strategies focused on particular bacterial targets.

Keywords:
Urinary tract infection
Proteus mirabilis
Flagella
Biofilm
Catheter
Prevention
Resumen

Proteus mirabilis(P. mirabilis) es un agente etiológico común de infecciones del tracto urinario, en particular de aquellas asociadas con cateterización. P. mirabilis forma biofilms eficientemente en diferentes superficies y muestra un comportamiento multicelular llamado swarming, mediado por flagelos. Hasta el momento, el papel de los flagelos en la formación de biofilms de P. mirabilis ha estado en discusión. En este estudio, se evaluó el papel de los flagelos de P. mirabilis en la formación de biofilms, utilizando una mutante isogénica generada por reemplazo alélico, incapaz de expresar flagelina. Se utilizaron diferentes enfoques, como la evaluación de la hidrofobicidad de la superficie celular, de la movilidad y la migración bacteriana sobre secciones de catéteres y medidas de biomasa y de la dinámica del biofilm mediante inmunofluorescencia y microscopia confocal, tanto en modelos estáticos como de flujo. Nuestros hallazgos indican que los flagelos de P. mirabilis desempeñan un papel en la formación de biofilms, aunque su falta no suprime por completo su generación. Asimismo, evidencian que la interferencia de la función flagelar puede contribuir a evitar la formación de biofilms en el contexto de estrategias centradas en blancos bacterianos particulares.

Palabras clave:
Infección del tracto urinario
Proteus mirabilis
Flagelos
Biofilm
Catéter
Prevención
Texto completo
Introduction

Proteus mirabilis(P. mirabilis) causes urinary tract infections (UTI), although it does not often colonize the normal unobstructed urinary tract1. It is more common in complicated UTI, particularly in catheter-associated urinary tract infections (CAUTIs)34.

P. mirabilis can cause urinary stones and crystalline biofilm formation associated with the increase of urine pH, due to urease production. Environmental changes caused by hydrolyzation of the urine urea allow the precipitation of minerals, promoting the formation of typical mineral-encrusted biofilms23. Due to encrustation, these crystalline biofilms may block the catheters in patients with CAUTIs. Sixty-two percent (62%) of patients with recurrent P. mirabilis catheter encrustation developed bladder stones because of catheter colonization25. Other possible consequences associated with crystalline biofilms and blockages of the urinary catheter are urine retention, along with bladder and urethra mucosal trauma17.

Different factors participate in biofilm development, including motility, which has often been considered a putative factor in this process21.

P. mirabilis typical swarming motility is produced when vegetative swimmer cells differentiate into elongated, multinucleated and highly flagellated swarmer cells1. This process, mediated by flagella, is initiated by bacterial contact with a solid surface and probably contributes to biofilm formation and catheter colonization. The role of flagella and swarming in P. mirabilis UTI is still under debate3,24. Different studies have suggested that flagella significantly contribute to P. mirabilis urovirulence22,24. However, several works indicate that flagella are not critical for establishing UTI by P. mirabilis and other uropathogens18,19,35.

The role of flagella in P. mirabilis biofilm formation remains unclear and is seldomly addressed in the literature. A few studies have proposed that flagella and motility may play a role in the formation of biofilms9, while others consider flagella not to be critical in this process16.

In this study, we assess the input of P. mirabilis flagella in biofilm formation using a flagellate mutant generated by allelic replacement, tested in different in vitro assays.

Materials and methodsBacterial strains

The clinical wild-type P. mirabilis Pr2921 strain was extensively characterized36. An isogenic non-flagellate allelic replacement mutant (AF strain) was used to evaluate the role of flagella in biofilm formation. This mutant has both flaA and flaB structural genes partially deleted and interrupted by a Kanamycin cassette26, following the procedure used to generate other flagellate mutants in our laboratory19. Absence of swimming and swarming motility was evaluated, and the lack of flagella was evidenced by Western blot28. Bacteria were cultured in Luria-Bertani (LB) broth or LB agar (1.5%). Artificial urine (AU) was prepared according to Scavone et al.27 Growth curves were first assessed in LB and AU to check that the absence of flagella did not affect normal growth.

Bacterial suspensions were prepared in phosphate-buffered saline (PBS) from fresh LB agar plates at an OD 600nm to inoculate LB or AU cultures in 96-multiwell plates27. pH of AU cultures of both strains was controlled serially.

Hydrophobicity of planktonic cells

Ten microliters of bacterial suspensions in PBS (OD540=0.2–0.3) were inoculated in 5ml of AU or LB, and incubated at 37°C for 48h. Then, bacterial suspensions (OD600=0.8) and 200μl of added xylene were mixed, shaken for 2min and left static for 20min. Subsequently, the aqueous phase (OD600nm) was measured and hydrophobicity was assessed according to Bibiloni et al.2. The assay was done in triplicate. Hydrophobicity of planktonic cells of the different strains and under different conditions was assessed using the Tukey's multiple comparison test.

Swimming and swarming motility

Swimming motility was evaluated as described by Hola et al.11, and swarming motility was assessed as described by Jones et al.15. Both assays were performed in triplicate.

Inhibition of swarming was evaluated using a specific P. mirabilis flagella rabbit anti-serum. For this purpose, a rabbit was immunized with four doses of 25μg of purified Pr2921 flagellin administered subcutaneously, using complete Freund's adjuvant (Sigma) for the first dose and incomplete Freund's adjuvant for the following ones, according to previous studies19. These procedures were approved by the Institutional Animal Care Committee and adequate measures were taken to minimize discomfort or stress of the animal. The antibody response was determined ten days after the last dose (day 55) and serum anti-flagella IgG titer measured by ELISA reached a value of 1:100000.

For the swarming inhibition assay, the WT strain was grown on 50mm diameter plates containing 5ml of modified LB agar and LB agar supplemented with the specific rabbit anti-serum, using a 1:10 dilution.

Bacterial migration across urethral catheters

The ability to migrate across urinary catheters sections was assessed following the procedure proposed by Stickler and Huges32. The catheter materials were silicone and latex (Teleflex Medical, Kernen, Germany). Migration was tested 15 times for both catheter types.

Quantification of biofilm formation on polystyrene multiwell plates

The effect of the flagellar mutation in biofilm formation was evaluated using the semi-quantification technique based on the adsorption of crystal violet (CV)6.

A competition assay was also performed to assess the ability of both strains to remain attached to the polystyrene surface, forming a biofilm when cultured simultaneously following the procedure described above. However, in this case, the biofilms were scrapped and bacteria were cultured in nutrient agar and nutrient agar supplemented with kanamycin since AF carries a kanamycin-resistance gene incorporated into the mutagenic process26. Biofilm formation of the different strains and under different conditions was assessed using the Tukey's multiple comparison test.

Biofilm formation over time by confocal laser scanning microscopy

Biofilm formation of Pr2921 and AF was evaluated in 2, 5 and 7 day-LB and AU cultures under static conditions at 37°C27. This method allows biofilm formation on a coverslip placed into a tube subjected to fluorescent staining after different incubation periods. Staining techniques and microscopy analyses were performed according to Schlapp et al.31. Bacteria were stained with Syto 9 (Molecular Probes) and the extracellular matrix with FilmTracer™ SYPRO® Ruby Biofilm matrix stain. 3D images were acquired using a Leica TCS LSI super-zoom confocal fluorescent microscope with an iXon Ultra 897 back-illuminated imaging EMCCD camera, LAS Software, a 100× oil immersion objective (NA=1.35) and 488/520, 450/610nm excitation/emission wavelength.

Three z-stacks were randomly chosen in each sample, using an acquisition step of 0.3μm in the z-axis and 1024×1024 pixels in the xy-plane with a pixel size of 170nm. After deconvolution using Huygens Software, segmentation, visualization, 3D reconstruction and biofilm parameter descriptors were calculated using ScianSoft31.

Bacterial number, bacterial and matrix volumes were calculated to compare biofilm evolution. Results were compared using one-way ANOVA p0.05.

Biofilm grown under a flow system

In order to evaluate biofilm formation under a flow system, we have developed a system that consists of a medium reservoir, a peristaltic pump, a chamber where the biofilm was grown and a disposal flask. The chamber had two slides (bottom and top) in order to follow the biofilm formation by confocal microscopy. The system was set up with a LB flow at 0.5ml/min. First, the system was assembled and after removing air bubbles, the bacterial suspension was introduced into the chambers through a three-way stop cock. The biofilm was allowed to form for 1h, after that the flow was started for 24, 48 and 72h. Acridine orange (0.01mg/ml) was used to stain and visualize bacteria in the biofilm. At different time points, the system was stopped and the dye was added to the system through the three-way stop cock. Visualization was performed in a LSM Zeiss 800, using a 63× oil immersion objective (NA 1.4). Live images were taken every 127s for 3min. After acquisition, the system was loaded again until the next time point.

Image processing of time-lapse biofilm

Image processing and analysis were performed using FIJI/ImageJ software30. Morphological analysis was performed using MicrobeJ plugin7. Morphological parameters were defined according to the different morphotypes of P. mirabilis described by Jansen et al.14 Swarmer cells with a length greater than 10μm and a maximum width of 3μm were excluded from the analysis. Thresholds were used for binarization and length/width exclusion criteria prior to analysis. Contour detection was performed using Fit-Shape mode. The shape descriptors calculated from the data were length, mean width and aspect ratio, defined as the length of the major axis divided by the minor axis of the ellipsoid fitted to each particle. Statistical analysis was performed by RStudio software (RStudio Team, 2020). The differences between each time-lapse were analyzed with the Wilcoxon test. Motility analyses were performed with TrackMate plugin8,33. Motility analysis was performed using previously segmented time-lapse image sequences by Ilastik software. TrackMate auto intensity threshold tool was used to select all particles for track analysis. The trajectories of each individual bacterium were determined by LAP Tracker. It was set allowing a frame-to-frame linking and gap closing of 6μm, splitting and merging was set at 0.6μm, and ellipse long axis, ellipse short axis and max intensity were used as penalties for linking cost calculation. Mean square displacements (MSD) were calculated with R Studio software by Eq. (1) (RStudio Team, 2020). RStudio: Integrated Development for R. RStudio, PBC, Boston, MA (URL http://www.rstudio.com).

ResultsLack of flagella did not affect bacterial features, except flagellin expression

Growth curves of Pr2921 and AF cultured in LB or AU were similar, showing that the general biology of the mutant was not affected, and both strains grew better in LB compared with AU (Fig. 1).

Figure 1.

Growth curves of Pr2921 P. mirabilis wild-type strain and flagellate mutant AF in LB broth (LB) and artificial urine (AU).

Growth curves were generated by serial OD measures of grown bacteria.

(0.06MB).

pH of Pr2921 and AF cultures in AU reached a value of 9 after 6h of incubation in both cases, remaining constant for at least 24h, demonstrating that urease production was similar in both strains. Expression of MR/P fimbriae assessed by Western blotting (Suppl. Fig. S1), hemagglutination based on MR/P fimbrial expression, and hemolysis observed on blood agar plates were similar in both strains (data not shown).

Genetic rearrangements due to allelic replacement mutagenesis were as expected and the mutant was unable to express flagellin28.

Hydrophobicity index is increased in AU

When bacteria were grown in LB, no significant differences were observed among the hydrophobicity indexes between both strains. However, when bacteria were grown in AU, the AF mutant exhibited a significant hydrophobicity increase compared with the wild-type Pr2921, in AU (p<0.001) (Fig. 2). In addition, hydrophobicity of planktonic bacteria grown in AU was significantly higher than bacteria grown in LB, in the case of both strains (p<0.05, Fig. 2).

Figure 2.

Hydrophobicity of Pr2921 P. mirabilis wild-type strain and flagellate mutant AF grown in LB broth (LB) and artificial urine (AU).

When bacteria were grown in AU, the AF mutant exhibited a significant hydrophobicity increase compared with the wild-type Pr2921 strain in AU (p<0.001). Hydrophobicity was significantly higher in AU than in LB in the case of both strains (p<0.05). Statistical differences were calculated using the Tukey's multiple comparison test, **p<0.005, ***p<0.0005, ****p<0.0001.

(0.17MB).
Swimming and swarming motility and migration across latex and silicone catheter bridges

The flagellate mutant was unable to swim or swarm (Suppl. Fig. S2). In both assays, the mutant grew to form a defined colony without spreading beyond the colony limits.

Swarming was completely inhibited when the WT strain (Pr2921) grew on LB agar supplemented with specific anti-flagella rabbit serum (1:10). Lower serum concentrations obtained by serial dilutions inhibited swarming in a dose-dependent relationship (data not shown).

The influence of flagella on P. mirabilis migration across catheter sections was assessed. The WT strain crossed latex and silicone catheter bridges in every case (15/15), while the AF mutant was unable to cross any catheter sections (0/15) (Suppl. Fig. S2).

Biofilm formation on polystyrene

When biofilm formation was evaluated using the method based on associated CV adsorption, the AF mutant showed a significantly impaired ability to form biofilms compared to WT Pr2921 in LB (p<0.0001).

When the assay was performed using AU, the level of biofilm formation of the mutant strain was lower than that formed by the WT strain but the difference was not significant (p>0.05) (Fig. 3). A significantly reduced biofilm was also observed when WT grew in AU compared with that observed in LB (p<0.0001).

Figure 3.

Biofilm formation on polystyrene surfaces assessed by the semi-quantitative method based on crystal violet staining.

Pr2921 P. mirabilis wild-type strain and flagellate mutant AF were grown in LB broth (LB) and in artificial urine (AU) and incubated at 37°C for 48h. Box plot of the OD values obtained in each condition are shown; asterisks show significant differences among different conditions. Statistical differences were calculated using the Tukey's multiple comparison test, **p<0.005, ****p<0.0001.

(0.08MB).

A competition assay was also performed to evaluate if the mutant was outcompeted by the WT strain in the biofilm. Results indicated that the wild-type strain outcompeted the mutant taking into account viable bacterial counts of Pr2921/AF from co-cultured biofilms. At 24h, wild type and mutant counts (log) were 7.63±0.01 and 2.28±0.2, respectively (p<0.05). After 48h, wild type and mutant counts remained at similar levels (7.28±0.07 and 2.64±0.09, respectively, p<0.05).

Biofilm formation dynamics

Biofilm formation was evaluated in LB and AU under static conditions at 37°C, at 2, 5 and 7 days of incubation, using CLSM and image analysis (Figs. 4 and 5).

Figure 4.

Bacteria and matrix volumes in biofilms formed by Pr2921 P. mirabilis wild-type strain and flagellate mutant AF in LB broth (LB) and artificial urine (AU) over time. Total bacteria and matrix volumes in biofilms formed in LB broth (LB) and artificial urine (AU) are shown in panels (A) and (B), respectively. *p0.05. The symbols represent the means of 3–5 random fields and their corresponding standard errors.

(0.1MB).
Figure 5.

3D reconstruction of biofilms formed by Pr2921 P. mirabilis wild-type strain and flagellate mutant AF in 7 day-cultures in LB broth (LB) and artificial urine (AU). All images were taken using the same magnification (63× oil immersion objective).

Bacteria are represented in green and the matrix in red.

D2: two day-cultures; D5: five day-cultures; D7: seven day-cultures.

The scale bar represents 10μm.

(0.75MB).

When biofilm formation was assessed after 2 days in LB or AU, the bacterial volume and the extracellular matrix of WT and the flagellate mutant AF were similar, showing in general low values with no significant differences among strains or media conditions (p>0.05) (Fig. 4). However, after 5 days, significant differences were observed among WT and the mutant AF strains grown in LB. The WT bacterial and matrix volumes significantly increased compared to the AF mutant (p<0.0001 in both cases). When both strains were cultured in AU, no AF bacteria remained attached to the coverslip, while WT Pr2921 exhibited a structured biofilm. However, the statistical difference was not significant since the WT biofilm was small. Furthermore, the AF matrix in AU was almost inexistent.

After 7 days of incubation in LB, the bacterial and matrix volume of the biofilm formed by WT 2921 decreased and differences were not significant when compared to the biofilm formed by AF (p>0.05). When bacteria were cultured in AU, no statistical differences between strains were identified; however, a small WT 2921 biofilm (both bacteria and matrix) was still observed, but not with the AF mutant (Figs. 4 and 5).

The dynamic system allowed in vivo observation of the biofilm every 24h (Fig. 6A). Both strains formed biofilm, but differences were observed between WT and the AF mutant. At 24h, biofilms were flat as observed by the height in the 3D stacks (Fig. 6B upper panels). WT 2921 biofilm was around 1.25μm in height while the AF biofilm was 0.75μm in height. Moreover, significant differences were observed in the size and shape of the bacteria (Fig. 6B). WT 2921 was more elongated than AF as represented by the mean width (the length of the major axis divided by the minor axis of the ellipsoid fitted to each bacteria) (Figs. 6B and C). At 48h, WT 2921 increased the 3D biofilm structure reaching 2μm in height and forming channels while the AF biofilm remained flat. At 72h, AF showed a compacted and thin biofilm with shortened bacteria and WT 2921 had a heterogeneous bacterial morphology within a 3D biofilm with the presence of channels (Fig. 6B, Suppl. MSD). While WT 2921 formed a mature biofilm with different bacterial morphologies, the AF mutant strain showed a flat biofilm and the morphology of the bacteria was reduced over time. With regard to the length of the bacteria, we observed that 2921 acquired a more elongated morphology while AF was shortened (Figs. 6B and C).

Figure 6.

Time-lapse biofilms. (A) The dynamic flow system that consists of a medium reservoir (a), a peristaltic pump (b), the 3-way stop cock (c), the biofilm chamber (d) and the disposal flask (e). (B) Representative 3D stacks of each time point (24, 48 and 72h) of Pr2921 (left) and AF (right). The scale bar represents 10μm, and applies to all images. (C) Aspect ratio, defined as the length of the major axis divided into the minor axis of the ellipsoid that is fitted to each particle. Significant differences were calculated using the *** P<0.05.

(1.17MB).
Discussion

P. mirabilis is among the most frequent causes of complicated UTI28, and displays a broad and complex range of virulence factors that may participate in the colonization of different surfaces12,27.

Flagella have been associated with the formation of biofilms in different pathogens, including Bacillus cereus, Yersinia enterocolitica and Helicobacterpylori10,20. However, the role of flagella and swarming motility in P. mirabilis UTI and biofilm formation has been thoroughly debated19,22,29.

In this study, we used a flagellate mutant to assess the role of flagella in P. mirabilis biofilm formation, through different experimental in vitro approaches, which are discussed below.

Growth patterns were similar when WT Pr2921 and the AF mutant were grown in LB broth or AU, indicating that the mutation did not alter the general bacterial biology. In addition, a series of phenotypic pathogenic features were not altered by the mutagenesis process, including urease production, fimbriae expression, hemagglutination and hemolysis production.

The influence of flagella on P. mirabilis surface-related features was assessed by measuring bacterial hydrophobicity. According to different authors, bacterial surface hydrophobicity is important for adherence to different interfaces and biofilm formation4. When the flagellate mutant was grown in LB broth, bacterial hydrophobicity did not vary. However, when grown in AU, hydrophobicity significantly increased, probably associated with an increased exposure of the lipid components of the bacterial surface. In other studies, no clear relationships between bacterial hydrophobicity and enhancement of binding to different substrates were observed5.

In this study, we also assessed the ability of the isogenic flagellate mutant to swim, swarm and migrate over catheter sections of different materials. The mutant was unable to swim or swarm on LB agar or to migrate along sections of latex and silicone catheters, strongly confirming the role of flagella in the colonization of these clinical devices. These results are in accordance with previous studies15.

The inclusion of specific P. mirabilis antiflagella antibodies in the culture medium also resulted in the abolition of motility, reinforcing the clear and specific role of flagellar function in motility and spreading over different surfaces through an indirect approach.

When biofilm formation was assessed on an abiotic surface like polystyrene, the flagellate mutant grown in LB showed a significant smaller biofilm compared with the wild type Pr2921. When bacteria grew in AU, the mutant also formed a smaller biofilm although differences were not significant. In this case, it must be taken into account that P. mirabilis growth in AU was significantly less abundant than in LB broth, influencing the magnitude of growth differences in both strains.

A competition assay based on the wild type and the mutant co-cultivation was performed to refine the assessment of flagella contribution in biofilm formation. We had used this kind of approach before to detect subtle effects of different P. mirabilis virulence factors in ascending UTI in mice13. Results of this assay revealed that although the mutant was outcompeted by the WT strain, a biofilm was formed that even persisted for at least 48h, indicating that biofilm formation was not completely abolished by the lack of flagella.

When CLSM was used to assess biofilm formation in LB broth and AU, significant differences were observed among biofilm parameters at different stages. One of the most notorious differences was the impaired capacity of the AF mutant to grow and produce extracellular matrix at the biofilm maturation stage in the static model (5 days). At this stage, the AF mutant biofilm had almost disappeared in AU while the WT biofilm, although small, remained attached and showing a typical mature structure, remaining attached even after 7 days. Our results confirm that flagella are important for biofilm formation, under different conditions. Furthermore, differences in bacterial morphology were observed under dynamic conditions, but the AF mutant was able to form a biofilm.

Different authors have reported that mutations of P. mirabilis virulence genes have different effects on biofilm formation that can induce a decrease or even an increase in matrix or bacterial biovolumes12,36.

Several studies have reported the role of bacterial flagella in adhesion to biotic and abiotic surfaces, including P. mirabilis, which can contribute to the initial contact with different surfaces and even among cells15,35.

As mentioned above, Jones et al.16 suggested that neither swarming nor swimming motility are required for the attachment of P. mirabilis to catheters and that mutants unable to swarm and swim formed crystalline biofilms and blocked catheters even more rapidly than the wild-type strain. The authors hypothesize that on contact with a surface, the non-swarmer cells are more likely to remain at the site of attachment, divide or produce microcolonies that initiate biofilm formation. On the other hand, Fusco et al.9 compared different P. mirabilis strains and reported that motility ability was related to biofilm formation; however, they did not use isogenic mutants.

Conclusion

Overall, our results show that flagella critically contribute to the formation of P. mirabilis biofilms. However, the lack of this organelle could not completely prevent biofilm formation, suggesting that different elements drive biofilm formation and persistence. Like other factors (e.g., ATF fimbria)36, flagella could play a significant role in biofilm formation on abiotic surfaces rather than in urinary tract colonization and infection.

This knowledge could contribute to the design of strategies for P. mirabilis biofilm prevention targeting the flagellar function, possibly in combination with other specific mechanisms.

Conflict of interest

The authors declare that they have no conflict of interest.

Acknowledgments

This research was supported by grant FCE4760 awarded by ANII-Uruguay and PEDECIBA-Uruguay. JJW is supported by FONDECYT3220832. SH is supported by the Chilean Millennium Science InitiativeP09-015-F, FONDECYT 1181823, DAAD57519605, MINEDUCRED 21994, CORFO16CTTS-66390 and AUCI Program for South-South Collaboration Uruguay-Chile, ACM 170003.

Appendix A
Supplementary data

The following are the supplementary data to this article:

References
[1]
C.E. Armbruster, H.L.T. Mobley, M.M. Pearson.
Pathogenesis of Proteus mirabilis infection.
[2]
R. Bibiloni, P.F. Pérez, G.L. Garrote, E.A. Disalvo, G.L. De Antoni.
Surface characterization and adhesive properties of bifidobacteria.
Methods Enzymol, 336 (2001), pp. 411-427
[3]
L.S. Burall, J.M. Harro, X. Li, C.V. Lockatell, S.D. Himpsl, J.R. Hebel, D.E. Johnson, H.L. Mobley.
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
Infect Immun, 72 (2004), pp. 2922-2938
[4]
G. Czerwonka, A. Guzy, K. Kałuża, M. Grosicka, M. Dańczuk, Ł. Lechowicz, D. Gmiter, P. Kowalczyk, W. Kaca.
The role of Proteus mirabilis cell wall features in biofilm formation.
Arch Microbiol, 198 (2016), pp. 877-884
[5]
G.F. Costa, M.C. Tognim, C.L. Cardoso, F.E. Carrara-Marrone, L.B. Garcia.
Preliminary evaluation of adherence on abiotic and cellular surfaces of Acinetobacter baumannii strains isolated from catheter tips.
Braz J Infect Dis, 10 (2006), pp. 346-351
[6]
R. de los Santos, M. Fernández, S. Carro, P. Zunino.
Characterisation of Staphylococcus aureus isolated from cases of bovine subclinical mastitis in two Uruguayan dairy farms.
Arch Med Vet, 46 (2014), pp. 315-320
[7]
A. Ducret, E.M. Quardokus, Y.V. Brun.
MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis.
Nat Microbiol, 1 (2016), pp. 16077
[8]
D. Ershov, M.-S. Phan, J.W. Pylvänäinen, S.U. Rigaud, L. Le Blanc, A. Charles-Orszag, R. James, W. Conway, F. Romain, N. Laine, N.H.P. Roy, D. Bonazzi, G. Duménil, G. Jacquemet, J.Y. Tinevez.
Bringing TrackMate into the era of machine-learning and deep-learning.
[9]
A. Fusco, L. Coretti, V. Savio, E. Buommino, F. Lembo, G. Donnarumma.
Biofilm formation and immunomodulatory activity of Proteus mirabilis clinically isolated strains.
Int J Mol Sci, 18 (2017), pp. 414
[10]
S. Hathroubi, J. Zerebinski, K.M. Ottemann.
Helicobacter pylori biofilm involves a multigene stress-biased response, including a structural role for flagella.
MBio, 9 (2018), pp. e01973-e2018
[11]
V. Hola, T. Peroutkova, F. Ruzicka.
Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
FEMS Immunol Med Microbiol, 65 (2012), pp. 343-349
[12]
N. Holling, D. Lednor, S. Tsang, A. Bissell, L. Campbell, J. Nzakizwanayo, C. Dedi, J.A. Hawthorne, G. Hanlon, L.A. Ogilvie, J.P. Salvage, B.A. Patel, L.M. Barnes, B.V. Jones.
Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis.
Infect Immun, 82 (2014), pp. 1616-1626
[13]
A. Jacobs, H.Y. Chenia.
Biofilm formation and adherence characteristics of an Elizabethkingia meningoseptica isolate from Oreochromis mossambicus.
Ann Clin Microbiol Antimicrob, 10 (2011), pp. 16
[14]
A.M. Jansen, C.V. Lockatell, D.E. Johnson, H.L. Mobley.
Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection.
Infect Immun, 71 (2003), pp. 3607-3613
[15]
B.V. Jones, R. Young, E. Mahenthiralingam, D.J. Stickler.
Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection.
Infect Immun, 72 (2004), pp. 3941-3950
[16]
B.V. Jones, E. Mahenthiralingam, N.A. Sabbuba, D.J. Stickler.
Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters.
J Med Microbiol, 54 (2005), pp. 807-813
[17]
S.M. Jones, J. Yerly, Y. Hu, H. Ceri, R. Martinuzzi.
Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media.
FEMS Microbiol Lett, 268 (2007), pp. 16-21
[18]
M.C. Lane, V. Lockatell, G. Monterosso, D. Lamphier, J. Weinert, J.R. Hebel, D.E. Johnson, H.L. Mobley.
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.
Infect Immun, 73 (2005), pp. 7644-7656
[19]
C. Legnani-Fajardo, P. Zunino, C. Piccini, A. Allen, D. Maskell.
Defined mutants of Proteus mirabilis lacking flagella cause ascending urinary tract infection in mice.
Microb Pathog, 21 (1996), pp. 395-405
[20]
I. Liaqat, S.A. Mirza, R. Iqbal, N.M. Ali, G. Saleem, S. Majid, M. Shahid.
Flagellar motility plays important role in biofilm formation of Bacillus cereus and Yersinia enterocolitica.
Pak J Pharm Sci, 31 (2018), pp. 2047-2052
[21]
A. Luo, F. Wang, D. Sun, X. Liu, B. Xin.
Formation development, and cross-species interactions in biofilms.
Front Microbiol, 12 (2022), pp. 757327
[22]
H.L. Mobley, R. Belas, V. Lockatell, G. Chippendale, A.L. Trifillis, D.E. Johnson, J.W. Warren.
Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection.
Infect Immun, 64 (1996), pp. 5332-5340
[23]
A.N. Norsworthy, M.M. Pearson.
From catheter to kidney stone: the uropathogenic lifestyle of Proteus mirabilis.
Trends Microbiol, 25 (2017), pp. 304-315
[24]
M.M. Pearson, A. Yep, S.N. Smith, H.L. Mobley.
Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression.
Infect Immun, 79 (2011), pp. 2619-2631
[25]
N.A. Sabbuba, D.J. Stickler, E. Mahenthiralingam, D.J. Painter, J. Parkin, R.C. Feneley.
Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical.
J Urol, 171 (2004), pp. 1925-1928
[26]
P. Scavone, S. Villar, A. Umpiérrez, P. Zunino.
Role of Proteus mirabilis MR/P fimbriae and flagella in adhesion, cytotoxicity and genotoxicity induction in T24 and Vero cells.
Pathog Dis, 73 (2015), pp. ftv017
[27]
P. Scavone, V. Iribarnegaray, A.L. Caetano, G. Schlapp, S. Härtel, P. Zunino.
Fimbriae have distinguishable roles in Proteus mirabilis biofilm formation.
Pathog Dis, 74 (2016), pp. ftw033
[28]
P. Scavone, A. Umpiérrez, A. Rial, J.A. Chabalgoity, P. Zunino.
Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
Antonie Van Leeuwenhoek, 105 (2014), pp. 1139-1148
[29]
J.N. Schaffer, M.M. Pearson.
Proteus mirabilis and urinary tract infections.
[30]
J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J.Y. Tinevez, D.J. White, V. Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona.
Fiji: an open-source platform for biological-image analysis.
Nat Methods, 9 (2012), pp. 676-682
[31]
G. Schlapp, P. Scavone, P. Zunino, S. Härtel.
Development of 3D architecture of uropathogenic Proteus mirabilis batch culture biofilms – a quantitative confocal microscopy approach.
J Microbiol Methods, 87 (2011), pp. 234-240
[32]
D.J. Stickler, G. Hughes.
Ability of Proteus mirabilis to swarm over urethral catheters.
Eur J Clin Microbiol Infect Dis, 18 (1999), pp. 206-208
[33]
J.-Y. Tinevez, N. Perry, J. Schindelin, G.M. Hoopes, G.D. Reynolds, E. Laplantine, S.Y. Bednarek, S.L. Shorte, K.W. Eliceiri.
TrackMate: an open and extensible platform for single-particle tracking.
[34]
F. Yuan, Z. Huang, T. Yang, G. Wang, P. Li, B. Yang, J. Li.
Pathogenesis of Proteus mirabilis in catheter-associated urinary tract infections.
Urol Int, 105 (2021), pp. 354-361
[35]
P. Zunino, C. Piccini, C. Legnani-Fajardo.
Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
Microb Pathog, 16 (1994), pp. 379-385
[36]
P. Zunino, L. Geymonat, A.G. Allen, C. Legnani-Fajardo, D.J. Maskell.
Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection.
FEMS Immunol Med Microbiol, 29 (2000), pp. 137-144
Copyright © 2023. Asociación Argentina de Microbiología
Descargar PDF
Opciones de artículo
Herramientas
Material suplementario
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos